🔗 Permalink

Inventor profile of:

Osama Suleiman

City:

Cambridge

Country:

United Kingdom

Published Applications:

Last publication date:

2026-03-05

Top Assignees for applications by Osama Suleiman

The entities that hold a legal rights for patent applications filed by inventor Suleiman Osama:

MEREO BIOPHARMA 1 LIMITED 3 LONDON, United Kingdom
PULMOCIDE LIMITED 2 London, United Kingdom
INCYTE CORPORATION 2 Wilmington, DE United States
Aldeyra Therapeutics, Inc. 1 Lexington, MA United States
RENEO PHARMACEUTICALS, INC. 1 Irvine, CA United States
KIORA PHARMACEUTICALS GMBH 1 Vienna, Austria
Relay Therapeutics, Inc. 1 Cambridge, MA United States
PANOPTES PHARMA GMBH 1 Vienna, Austria
RENEO PHARMACEUTICALS, INC. 1 San Diego, CA United States

Recent patent applications by Suleiman Osama

Osama Suleiman from Cambridge, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-05

US20260060980A1

Human necessities

POLYMORPHS OF TRIAZOLE ANTIFUNGAL COMPOUND PC945

#2 | 2025-10-30

US20250333416A1

Chemistry; metallurgy

PROCESS FOR MAKING A PD-1/PD-L1 INHIBITOR AND SALTS AND CRYSTALLINE FORMS THEREOF

#3 | 2025-07-31

US20250243204A1

Chemistry; metallurgy

FGFR INHIBITORS AND METHODS OF MAKING AND USING THE SAME

#4 | 2024-05-16

US20240158395A1

Chemistry; metallurgy

PROCESS FOR MAKING A PD-1/PD-L1 INHIBITOR AND SALTS AND CRYSTALLINE FORMS THEREOF

#5 | 2024-01-04

US20240002356A1

Chemistry; metallurgy

CRYSTALLINE PPAR-DELTA AGONIST

#6 | 2023-09-14

US20230286938A1

Chemistry; metallurgy

Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor

#7 | 2023-01-26

US20230028714A1

Human necessities

POLYMORPHS OF TRIAZOLE ANTIFUNGAL COMPOUND PC945

#8 | 2022-06-23

US20220194946A1

Chemistry; metallurgy

FGFR inhibitors and methods of making and using the same

#9 | 2022-05-12

US20220144831A1

Chemistry; metallurgy

Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof

#10 | 2022-05-05

US20220135532A1

Chemistry; metallurgy

Crystalline PPARδ agonist

#11 | 2022-01-27

US20220024888A1

Chemistry; metallurgy

Crystalline PPAR-delta agonist

#12 | 2021-07-08

US20210206726A1

Chemistry; metallurgy

Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide

#13 | 2019-11-21

US20190352269A1

Chemistry; metallurgy

Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide

#14 | 2019-10-17

US20190315694A1

Chemistry; metallurgy

Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide

#15 | 2018-09-20

US20180265474A1

Chemistry; metallurgy

Polymorphic compounds and uses thereof

#16 | 2018-03-15

US20180072739A1

Chemistry; metallurgy

CO-CRYSTALS OF A BRUTON'S TYROSINE KINASE INHIBITOR

InventorID:

2139587 ⎘